ROLE OF THE BETA(3)-ADRENERGIC RECEPTOR LOCUS IN OBESITY AND NONINSULIN-DEPENDENT DIABETES AMONG MEMBERS OF CAUCASIAN FAMILIES WITH A DIABETIC SIBLING PAIR
Sc. Elbein et al., ROLE OF THE BETA(3)-ADRENERGIC RECEPTOR LOCUS IN OBESITY AND NONINSULIN-DEPENDENT DIABETES AMONG MEMBERS OF CAUCASIAN FAMILIES WITH A DIABETIC SIBLING PAIR, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4422-4427
Obesity and insulin resistance are important risk factors for the deve
lopment of noninsulin-dependent diabetes (NIDDM) and are prevalent amo
ng predisposed first degree relatives of diabetic individuals. Recent
molecular screening and analysis of a common missense mutation of the
beta(3)-adrenergic receptor gene suggested this locus as a strong cand
idate for increased obesity, earlier age of diabetes onset, and insuli
n resistance. To test the hypothesis that the beta(3)-adrenergic recep
tor locus affects diabetes susceptibility, obesity as measured by body
mass index, and components of the insulin resistance syndrome, we exa
mined the role of this region in families ascertained for two or more
NIDDM siblings. Linkage analysis was conducted using both parametric a
nd nonparametric analyses, including multipoint sibling pair analysis.
We found no evidence for linkage to NIDDM as a dichotomsus trait and
no evidence for Linkage to body mass index, waist/hip ratio, insulin l
evels, or glucose levels as quantitative traits or to reported age of
onset among NIDDM individuals. The Trp(64) Arg missense mutation was p
resent in 11% of the population. The mutation was not associated with
NIDDM, and Arg(64) carriers did not have earlier NIDDM onset, higher b
ody mass index, or higher waist/hip ratio than Trp(64) homozygotes. Am
ong relatives, Arg(64) carriers had significantly lower fasting glucos
e levels and lower waist/hip ratios than Trp(64) homozygotes, but no c
haracteristics of the insulin resistance syndrome. We conclude that th
e beta(3)-adrenergic receptor locus does not play an important role in
NIDDM susceptibility or in the insulin resistance syndrome among memb
ers of families with a strong predisposition to NIDDM.